For many years, it was believed that when an individual develops liver scarring, it can not be reversed. Today, we know that ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

Liver fibrosis represents a serious worldwide health issue with a prevalence of around 5% in general populations.1 The most ...

Cardiac fibrosis, a hallmark of heart failure and various cardiomyopathies, represents a complex pathological process that has long challenged therapeutic intervention. High-throughput omics ...

Fibrosis, a characteristic of all chronic kidney diseases (CKD), is now recognized to be an independent predictor of disease ...

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a ...

AI-based screening with transient elastography is more cost-effective than standard diagnostic approaches in identifying adults at risk for MASLD with advanced fibrosis.

Research suggests scientists have identified what drives the development of scar tissue in the intestines of people with Crohn’s disease. Scientists found clusters of immune cells in the gut which may ...

Fibrosis is the body's way of patching up damage—a bit like fixing a pothole. When skin is cut or a muscle is injured, ...

After false starts and incremental gains, scientists crack the problem that made breathing impossible. Will answers come fast ...